术后再入院与手术质量的相关性:采用德尔菲共识流程识别相关诊断编码
该研究采用改良德尔菲流程,由14名来自退伍事务部和私立机构的医疗与非医疗再入院专家,对2008至2014财年某退伍事务部医疗中心住院手术后的30天再入院进行3轮共识评定,判断再入院原因是否反映索引住院的手术质量。专家对50个再入院原因达成共识,感染、脓毒症、肺炎、出血/血肿、贫血、造口并发症、急性肾衰竭、水电解质紊乱或静脉血栓栓塞等诊断被认为与手术质量相关,占39664例再入院中的25521例(64%)。被认为与手术质量无关的再入院比例因手术而异,从下肢截肢术后再入院的21%(613/2331)到胆囊切除术后再入院的47%(745/1598)。作者认为约三分之一术后再入院不太可能反映手术质量问题,未来研究应检验将再入院限制于特定ICD-9编码是否能产生更有用的质量指标。
要点
- 14名专家经3轮德尔菲共识对50个再入院原因达成一致,判断其是否反映索引住院手术质量。
- 感染、脓毒症、肺炎、出血/血肿、贫血、造口并发症、急性肾衰竭、水电解质紊乱、静脉血栓栓塞等被认为与手术质量相关,占39664例再入院中的25521例(64%)。
- 被认为与手术质量无关的再入院比例因手术而异:下肢截肢术后21%(613/2331),胆囊切除术后47%(745/1598)。
- 作者认为约三分之一术后再入院不太可能反映手术质量问题,未来研究应检验限制于特定ICD-9编码的再入院能否成为更有用的质量指标。
适用人群与场景
- 2008至2014财年某退伍事务部医疗中心住院手术后的30天再入院,索引手术时间为2007年10月1日至2014年9月30日。
诊断标准与关键阈值
- 再入院原因按国际疾病分类第九版(ICD-9)诊断编码分组,专家对「该再入院原因是否反映索引住院可能的手术质量照护问题」按1分(从不相关)至5分(直接相关)评分。
研究设计与关键结果
- 改良德尔菲流程中14名专家经3轮共识对50个再入院原因达成一致,12名专家在第1轮与第2轮之间还完成了小组电话会议。
- 感染、脓毒症、肺炎、出血/血肿、贫血、造口并发症、急性肾衰竭、水电解质紊乱或静脉血栓栓塞等诊断被认为与手术质量相关,占39664例再入院中的25521例(64%的再入院;占340858例索引手术的7.5%)。
- 被认为与手术质量无关的再入院比例因手术而异,从下肢截肢术后再入院的21%(613/2331)到胆囊切除术后再入院的47%(745/1598)。
证据类型、等级与局限
- 证据类型:改良德尔菲共识流程。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为约三分之一术后再入院不太可能反映手术质量问题。
- 作者认为未来研究应检验将再入院限制于特定ICD-9编码是否能产生更有用的质量指标。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Postoperative readmission data are used to measure hospital performance, yet the extent to which these readmissions reflect surgical quality is unknown.
OBJECTIVE: To establish expert consensus on whether reasons for postoperative readmission are associated with the quality of surgery in the index admission.
DESIGN, SETTING, AND PARTICIPANTS: In a modified Delphi process, a panel of 14 experts in medical and surgical readmissions comprising physicians and nonphysicians from Veterans Affairs (VA) and private-sector institutions reviewed 30-day postoperative readmissions from fiscal years 2008 through 2014 associated with inpatient surgical procedures performed at a VA medical center between October 1, 2007, and September 30, 2014. The consensus process was conducted from January through May 2017. Reasons for readmission were grouped into categories based on International Classification of Diseases, Ninth Revision (ICD-9) diagnosis codes. Panelists were given the proportion of readmissions coded by each reason and median (interquartile range) days to readmission. They answered the question, "Does the readmission reason reflect possible surgical quality of care problems in the index admission?" on a scale of 1 (never related) to 5 (directly related) in 3 rounds of consensus building. The consensus process was completed in May 2017 and data were analyzed in June 2017.
MAIN OUTCOMES AND MEASURES: Consensus on proportion of ICD-9-coded readmission reasons that reflected quality of surgical procedure.
RESULTS: In 3 Delphi rounds, the 14 panelists achieved consensus on 50 reasons for readmission; 12 panelists also completed group telephone calls between rounds 1 and 2. Readmissions with diagnoses of infection, sepsis, pneumonia, hemorrhage/hematoma, anemia, ostomy complications, acute renal failure, fluid/electrolyte disorders, or venous thromboembolism were considered associated with surgical quality and accounted for 25 521 of 39 664 readmissions (64% of readmissions; 7.5% of 340 858 index surgical procedures). The proportion of readmissions considered to be not associated with surgical quality varied by procedure, ranging from to 21% (613 of 2331) of readmissions after lower-extremity amputations to 47% (745 of 1598) of readmissions after cholecystectomy.
CONCLUSIONS AND RELEVANCE: One-third of postoperative readmissions are unlikely to reflect problems with surgical quality. Future studies should test whether restricting readmissions to those with specific ICD-9 codes might yield a more useful quality measure.
参考来源
- Mull HJ, Graham LA, Morris MS, et al. Association of Postoperative Readmissions With Surgical Quality Using a Delphi Consensus Process to Identify Relevant Diagnosis Codes. JAMA Surg. 2018. PMID: 29710234. doi:10.1001/jamasurg.2018.0592
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。